1. Home
  2. List
Reference Patent

Reference - List

  • 17 Hits
  • Search Condition : Filter (MeSH = Pancreatic Neoplasms* / genetics)
Species Resource Title
Human and Animal Cells PANC-1(RCB2095) Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metabolism interference in pancreatic cancer.
Human and Animal Cells CTLL-2(RCB0637) Silencing of tumoral carbohydrate sulfotransferase 15 reactivates lymph node pancreatic cancer T cells in mice.
Human and Animal Cells PANC-1(RCB2095) High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer.
Human and Animal Cells PK45-P(RCB2141) , PK45-H(RCB1973) , PK-8(RCB2700) , PK-59(RCB1901) , KP-4(RCB1005) Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis.
Human and Animal Cells PANC-1(RCB2095) CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses.
Human and Animal Cells PK-45H(RCB1973) , PK-59(RCB1901) , MIA Paca2(RCB2094) , PANC-1(RCB2095) , PK-1(RCB972) Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor.
Human and Animal Cells T3M-4(RCB1021) Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer.
Human and Animal Cells , Drosophila MIA Paca2(RCB2094) , PANC-1(RCB2095) Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma.
Human and Animal Cells PK-8(RCB2700) High ARHGEF2 (GEF-H1) Expression is Associated with Poor Prognosis Via Cell Cycle Regulation in Patients with Pancreatic Cancer.
Human and Animal Cells PANC-1(RCB2095) ERAP2 is a novel target involved in autophagy and activation of pancreatic stellate cells via UPR signaling pathway.
Human and Animal Cells PANC-1(RCB2095) Impact of Capicua on Pancreatic Cancer Progression.
Human and Animal Cells MIA Paca2(RCB2094) , NB1RGB(RCB0222) Time-saving method for directly amplifying and capturing a minimal amount of pancreatic tumor-derived mutations from fine-needle aspirates using digital PCR.
Human and Animal Cells Hep G2(RCB1886) Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN).
Human and Animal Cells PK-1(RCB1972) , PK-8(RCB2700) , PK-45H(RCB1973) MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
Human and Animal Cells PANC-1(RCB2095) Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer.
Human and Animal Cells T3M-4(RCB1021) Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer.